Marker Therapeutics (MRKR) Stock Chart & Stock Price History $1.25 +0.06 (+5.02%) Closing price 05/2/2025 03:59 PM EasternExtended Trading$1.26 +0.01 (+0.48%) As of 05/2/2025 05:03 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Marker Therapeutics Stock Price Performance 5 Day Performance+1.63%1 Month Performance+23.64%3 Month Performance-33.51%6 Month Performance-64.49%Year-To-Date Performance-59.81%1 Year Performance-70.38% Receive MRKR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Marker Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address MRKR Stock Chart for Sunday, May, 4, 2025 MRKR Chart by TradingView Marker Therapeutics Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/02/2025$1.19$1.25+5.02%$1.30$1.2087,132 shs$13.39 million05/01/2025$1.19$1.19+0.03%$1.23$1.1929,776 shs$12.75 million04/30/2025$1.23$1.19-3.25%$1.24$1.1737,490 shs$12.74 million04/29/2025$1.26$1.23-2.38%$1.28$1.2216,753 shs$13.17 million04/28/2025$1.25$1.26+0.80%$1.30$1.2128,416 shs$13.49 million04/25/2025$1.27$1.25-1.57%$1.30$1.2431,751 shs$13.39 million04/24/2025$1.17$1.27+8.55%$1.28$1.1650,638 shs$13.60 million04/23/2025$1.19$1.17-1.68%$1.24$1.1728,697 shs$12.53 million04/22/2025$1.20$1.19-0.83%$1.25$1.1941,152 shs$12.74 million04/21/2025$1.15$1.20+4.35%$1.24$1.1257,642 shs$12.85 million Get the Latest News and Ratings for MRKR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Marker Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/18/2025$1.15$1.15$1.18$1.0634,574 shs$12.32 million04/17/2025$1.08$1.15+6.48%$1.18$1.0634,574 shs$12.32 million04/16/2025$1.17$1.08-7.69%$1.17$1.0620,447 shs$11.57 million04/15/2025$1.10$1.17+6.36%$1.19$1.1039,811 shs$12.53 million04/14/2025$1.03$1.10+6.80%$1.14$1.0443,166 shs$11.78 million04/11/2025$1.03$1.03$1.07$0.9940,565 shs$11.03 million04/10/2025$1.07$1.03-3.74%$1.10$1.0228,588 shs$11.03 million04/09/2025$1.05$1.07+1.90%$1.10$0.9664,382 shs$11.46 million04/09/2025$1.05$1.07+1.90%$1.10$0.9664,382 shs$11.46 million04/08/2025$1.01$1.05+3.96%$1.09$0.9645,994 shs$11.24 million04/08/2025$1.01$1.05+3.96%$1.09$0.9645,994 shs$11.24 million04/07/2025$1.01$1.01-0.10%$1.05$0.9538,207 shs$10.82 million04/04/2025$1.10$1.01-8.09%$1.11$1.00107,712 shs$10.83 million04/03/2025$1.20$1.10-8.33%$1.19$1.1024,496 shs$11.78 million Related Companies Kronos Bio Stock Price Chart Precision BioSciences Stock Price Chart Immix Biopharma Stock Price Chart OKYO Pharma Stock Price Chart PepGen Stock Price Chart Immuneering Stock Price Chart Karyopharm Therapeutics Stock Price Chart PMV Pharmaceuticals Stock Price Chart Avalo Therapeutics Stock Price Chart Citius Oncology Stock Price Chart Receive MRKR Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Marker Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MRKR) was last updated on 5/4/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Robots aren't coming to America in 2025. They are already here. Oxford Economics says, "The Robotics Rev...Weiss Ratings | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredWill May start the next "Great Depression?"You probably haven't heard about this yet... But this could be the biggest wealth building opportunity of t...Behind the Markets | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowThe July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...Crypto Swap Profits | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marker Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marker Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
